ClinicalTrials.Veeva

Menu

VCRC Tissue Repository

University of Pennsylvania logo

University of Pennsylvania

Status

Enrolling

Conditions

Giant Cell Arteritis
Eosinophilic Granulomatosis With Polyangiitis
Cutaneous Vasculitis
Polyarteritis Nodosa
Granulomatosis With Polyangiitis (Wegener's)
Henoch-Schonlein Purpura
Takayasu Arteritis
Microscopic Polyangiitis
Aortitis
Churg-Strauss Syndrome
IgA Vasculitis

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02967068
VCRC5511
U54AR057319 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Full description

Biopsy specimens collected as standard of care for these diseases will be retrieved and used in research. The most common biopsies performed are kidney, lung, skin, nerves, and vessels; however, other tissue is also of interest for the study. Biopsies are not performed as part of this protocol, rather we will request consent to collect biopsy specimens already collected under routine care.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562).

Exclusion criteria

  • Inability to give informed consent (or their guardians in the case of children) and to sign the consent form.
  • Unwilling to allow the use of their tissue for research.

Trial contacts and locations

8

Loading...

Central trial contact

Katie Doyle

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems